Mark S. Schroeder - 05 Nov 2022 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
EVP, President-Diagnostics Lab
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Mark S. Schroeder
Issuer symbol
LH
Transactions as of
05 Nov 2022
Net transactions value
-$208,990
Form type
4
Filing time
08 Nov 2022, 15:27:31 UTC
Previous filing
31 Mar 2022
Next filing
10 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise +2,010 +30% 8,697 05 Nov 2022 Direct F1, F2
transaction LH Common Stock Tax liability $208,990 -894 -10% $233.77 7,803 07 Nov 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Options Exercise $0 -2,010 -43% $0.000000 2,717 05 Nov 2022 Common Stock 2,010 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2 Amount includes 81.9033 shares acquired on June 30, 2022 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.
F3 Stock withholding to satisfy tax withholding obligations.
F4 The Restricted Stock Units vested in three equal annual installments beginning on November 5, 2020 and are now fully vested.
F5 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.